OBIO CAAP® 2017 Kicks Off Just As Toronto Health Innovation Week Launches
OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches.
OBIO Partner: StarFish Medical Acquires Kangaroo Design
OBIO Partner, StarFish Medical has acquired Kangaroo Design of Toronto, the leading medical device development company in Ontario.
OBIO Member: CCAB Innovative Collaboration Accelerating Cancer Treatments
OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB) and OBIO Partner, the National Research Council of Canada (NRC) have put in place over $1M in collaborative agreements over the past year to produce and test therapeutic antibodies discovered at the University of Toronto (U of T).
Ontario Bioscience Innovation Organization (OBIO®) Leadership Summit Hosts Top Health Science Minds to Define Future of the Industry
January 24, 2017 TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®) hosted a summit of industry, academic, government and investment leaders about the future of health science innovation in Canada. Attendees engaged in group discussions and heard from subject matter experts to extrapolate a mandate of action for anchoring health science companies in Ontario. The outcome of the summit lays a foundation for actionable business cases for private and public sector solutions to the health science industry’s biggest challenges: Innovation Pull, Adoption and Capital Attraction.
OBIO® CEO Gail Garland Selected as Founding Member of Springboard Enterprises Canadian Advisory Council
WASHINGTON, D.C. (January 19, 2017) – Springboard Enterprises (www.sb.co), a venture catalyst dedicated to promoting high growth potential companies led by women, announced the formation of the Springboard Canadian Advisory Council and its seven Founding Members. The Founding Members are connected influencers, investors, and innovators from the technology and life science sectors across Canada.
OBIO® Launches the Health 2 Business Bridge Program™ H2BB™ Improving Access to Business Trained Talent in Ontario’s Health Science Industry
CAAP Company: GaitTronics SoloWalk Featured in Ottawa Hospital Journal
GaitTronics SoloWalk has been tested with cerebral palsy patients at the Ottawa Children’s Treatment Centre. But geriatric patients have different needs, so they’re working with Dr. Huang and other GMU staff members to test the walker at TOH.
CAAP Company: BrainFx SCREEN Self Diagnostic Now Live
The BrainFx SCREEN, a 15 minute brain health check-up that answers the question, ‘Do I need more tests?’ Try it out today!
PreCAAP Company: Greenspace Mental Health Present Demo Video on Their Technolnogy
Greenspace Mental Health has created a new demo video on how therapists now automatically have their own test patient.
Pre-CAAP Company: Sojourn Labs Awarded $50,000 to Advance Their Technology in Support of a Lower-Carbon Future for Canada
Shell Canada's Quest Climate Grant has awarded three Canadian clean technology innovations with $50,000 per project to recognize their efforts in helping to combat climate change. The recipients were chosen based on their unique business and/or product concept and their commitment to working on promising climate change innovations.
OBIO Presents at Sunnybrook Medventions Innovation Day
OBIO was invited to speak at the Sunnybrook Medventions Innovation Day on Monday November 28th, presented by the Schulich Heart Program.
CAAP Company: ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise
ChipCare, a Toronto-based start-up diagnostic company, announced today that San Francisco-based life sciences investment bank Biotech Alliances International will serve as the lead investment banker for its $18.8 million Series B capital raise, $2.8 million of which has already been secured.
CAAP Company: Medella Health featured in JDRF
Medella Health featured in JDRF. JDRF is the leading global organization focused on type 1 diabetes (T1D) research.
CAAP Company: Tecla Featured onTech Toys segment on CTV Ottawa Morning Live
Watch the Tech Toys segment on CTV Ottawa Morning Live featuring Tecla and other awesome Tech gadgets!
Pre-CAAP Company: iamsick's #bookaflushot Campaign Featured in Online Technology Magazine ITBusiness.ca
iamsick.ca 's #bookaflushot campaign has been featured in the online technology magazine ITBusiness.ca
CAAP Company: AprilAge's Face Aging Software, APRIL® Now Being Used in 34 countries
AprilAge's Face Aging Software, APRIL®, is now being used in 34 countries by health and wellness educators, providers, and payors to show patients and customers in the most personal way possible (seeing their "future face"), the effects of risky lifestyle behaviors and conditions over time, including obesity, smoking, and excess sun exposure.
CAAP Company: KA Imaging Launches New Website
OBIO CAAP Company KA Imaging has launched their new website! KA Imaging is a High Resolution Imaging Technology company with a global reach.
CAAP Company: Medella Health Named International Runner-Up for James Dyson Award
Medella Health has been named an international runner-up for the James Dyson Award, an international competition that challenges product design, industrial design, and engineering university students to “design something that solves a problem.”
CAAP Company: QoC Health Publication in JMIR
This journal article describes the protocol for optimizing and evaluating Thought Spot, a Web- and mobile-based platform led by Centre for Addiction and Mental Health (CAMH) and co-created with end users that is designed to improve the ability of students to access mental health and substance use services. QoC Health is proud to be the technology partner on this important initiative.
CAAP Company: BrainFx is a Technology Partner for Canadian Institutes of Health Research (CIHR)
BrainFx is a Technology Partner for Canadian Institutes of Health Research (CIHR) Project to help youth with mental illness.